Brain Tissue Successfully Frozen & Thawed: Cryosleep Advances

The idea of long-term cryosleep, once firmly in the realm of science fiction, is edging closer to reality. Recent research published in the journal PNAS details a successful experiment where researchers were able to freeze and revive brain tissue from mice, restoring electrical signaling and even preserving the processes linked to learning, and memory. This doesn’t mean humans are about to be frozen for interstellar travel, but it does represent a significant shift in how scientists view the possibilities of cryopreservation.

Vitrification: A Glassy Solution to a Crystalline Problem

The primary obstacle to successful cryopreservation has always been ice crystal formation. As water freezes, it expands, creating sharp crystals that physically damage cells and disrupt their delicate internal structures. This mechanical tearing apart of tissue has historically rendered frozen biological material unusable. However, the team at Friedrich-Alexander University Erlangen-Nuremberg (FAU) and University Hospital Erlangen bypassed this issue using a technique called vitrification.

Vitrification, as the name suggests, aims to transform the water within tissue into a glass-like solid, rather than a crystalline one. This is achieved by replacing much of the tissue fluid with a carefully formulated cocktail of cryoprotective chemicals. Crucially, the cooling process must be rapid enough to prevent ice crystals from forming – essentially locking the molecules in place before they have a chance to organize into a crystalline structure. Both glass and ice are solid, but glass lacks the damaging, ordered structure of crystals.

The researchers utilized a custom solution, dubbed V3, designed to minimize toxicity to cells while effectively preventing ice formation. This solution was used in conjunction with a rapid cooling process involving a liquid-nitrogen-chilled copper cylinder reaching -196°C (-321°F), followed by storage at -150°C (-238°F) for periods ranging from ten minutes to seven days. You can find more details about the study methodology on the PNAS website.

Preserving Function: Beyond Structural Integrity

Upon thawing, the team found that the structure of the neurons within the hippocampal tissue – a brain region critical for memory and learning – was largely preserved. More importantly, the neurons were able to fire and communicate with each other, demonstrating restored electrical signaling. But the most compelling finding was the preservation of long-term potentiation (LTP).

LTP is a process where frequently used connections between neurons are strengthened, and is widely considered the cellular basis of learning and memory. Its persistence after complete freezing indicated that the intricate cellular machinery required for this process remained functional. As lead author Dr. Alexander German explained to BBC Science Focus, “The result tells us that this synaptic machinery remained sufficiently intact to support new plasticity after complete cryogenic arrest.” This suggests the vitrification process protected the tissue far better than previously anticipated.

Nature’s Cryoprotection: Lessons from the Siberian Salamander

Interestingly, the principles behind vitrification aren’t entirely new to nature. Some organisms have evolved remarkable strategies for surviving extreme cold. The Siberian salamander, for example, can endure temperatures as low as -58°F (-50°C) by entering a dormant state for extended periods. Its secret lies in its liver, which produces glycerol – a natural antifreeze that prevents ice crystal formation within its cells. A visual of this remarkable creature can be found here. While the salamander’s natural cryoprotection is impressive, replicating it in more complex organisms like mammals presents significant challenges.

Immediate Applications: Beyond Science Fiction

While whole-body cryopreservation remains a distant prospect, the implications of this research are already being explored in more practical applications. Currently, surgeons who remove brain tissue during epilepsy operations must analyze it immediately. A reliable vitrification method would allow these samples to be banked for future study, potentially unlocking new insights into neurological disorders.

Dr. German’s spin-out company, Hiber, is actively working to translate this technique into a service providing preserved human neural tissue for drug discovery and disease research. This could accelerate the development of new therapies by providing researchers with access to a consistent and reliable source of high-quality brain tissue.

Long-Term Storage and the Challenges Ahead

The physics of long-term storage also appear promising. Once tissue is cooled below the glass transition temperature, molecular movement and chemical degradation essentially halt, effectively pausing the biological clock. However, Dr. German notes that radiation exposure may pose a greater challenge, particularly for potential long-duration space missions.

Scaling this technique from thin tissue slices to whole organs – or even entire organisms – presents a formidable hurdle. In a slice, cryoprotectants can diffuse evenly throughout the tissue. In an intact brain, they must be delivered and removed via blood vessels, a process complicated by the blood-brain barrier. Uneven thawing could also lead to cracking or recrystallization, negating the benefits of vitrification. As Dr. German emphasizes, “Our PNAS study is a proof of principle in neural cryobiology, not a demonstration of whole-organism cryostasis.”

What Comes Next: From Proof of Concept to Clinical Application

The next steps involve refining the vitrification process to improve its efficiency and minimize potential toxicity. Researchers will also need to investigate methods for effectively delivering cryoprotectants to larger, more complex organs. Further studies are crucial to understand the long-term effects of vitrification on tissue function and to address the challenges of scaling up the technique for clinical applications. The team’s function opens a new avenue for research, shifting the conversation from “pure science fiction” to a “serious long-term scientific and engineering problem,” as Dr. German puts it. The focus now is on systematically addressing the remaining obstacles and translating this promising proof of concept into tangible benefits for medical research and, potentially, patient care.